The Effectiveness of Individualized Imagery Scripts on Sleep, Psychosis, and Suicidality Among Inpatients With Psychosis
Part of paid clinical trials in Houston, Texas.
- Sponsor
- The University of Texas Health Science Center, Houston
- Study ID
- NCT06194344
- Status
- Recruiting
Conditions
- Psychosis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Individualized imagery — BEHAVIORALStudy personnel will assist participants to create scripts that foster relaxation and safety. Objects, places, and/or scenarios that foster participant relaxation, sense of safety, and/or positive emotions will be identified. Participants will write or type the generated scenario using highly detailed elements (e.g., including visual, olfactory, auditory, tactile, and gustatory sensations, as applicable) associated with the imagery. Study personnel will assist with recording the imagery scripts; audio files will be recorded using an audio recording application. The imagery scripts will be played at night via Bluetooth earbuds connected to the Muse app and script recording while laying down to sleep. The imagery rehearsal prompts will play for approximately 15 minutes, based on 10-20-minute recommendations across imagery rehearsal therapy (IRT) studies
- Control — BEHAVIORALParticipants will wear the earbuds, with use of Muse S headband to collect outcome data without the individualized imagery scripts.
Study Details
The purpose of this study is to see how feasible is the use of compact EEG and paired audio technology to administer sleep interventions for inpatients with psychosis, to see if individuals that receive individualized technology-based sleep interventions experience improvements in sleep quality and to see if individuals that receive individualized technology-based sleep interventions experience improvements in symptomatology
Key Dates
- Start date
- Mar 5, 2024
- Status verified
- Jul 2025
- Primary completion
- Jun 1, 2026
- Completion
- Jun 1, 2026
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Individualized imagery
- Active Comparator: Control
Primary Outcome Measure
Feasibility as assessed by coding percentage of use per night (based on duration of physiological measures collected per night divided by hours of sleep) [ Time Frame: from start of intervention to end of intervention (upto 80 days after baseline ) ]
Central Contacts
- Alia Warner, Ph.D., ABPP713-486-2700
- Calvary Fielden, B.S.713-741-6087
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of Texas Health Science Center at Houston | Houston | Texas | 77030 | Jessica Badawi, Ph.D. (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
Related Studies
- Toward a Computationally-Informed, Personalized Treatment for HallucinationsEARLY_PHASE1 · Recruiting · Yale University · New Haven, Connecticut
- Normobaric Oxygen Therapy for Individuals With First-Episode PsychosisRecruiting · Nicholas Breitborde · Columbus, Ohio
- Neurobehavioral Mechanisms of Social Isolation and Loneliness in Serious Mental IllnessRecruiting · Massachusetts General Hospital · Charlestown, Massachusetts
- Targeting Processing Speed Deficits to Improve Social Functioning and Lower Psychosis RiskRecruiting · Northwell Health · Glen Oaks, New York